Please use this identifier to cite or link to this item:
Title: SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
Authors: Sundararajan, V. 
Tan, M.
Tan, T.Z. 
Ye, J. 
Thiery, J.P. 
Huang, R.Y.-J. 
Issue Date: 2019
Publisher: Nature Publishing Group
Citation: Sundararajan, V., Tan, M., Tan, T.Z., Ye, J., Thiery, J.P., Huang, R.Y.-J. (2019). SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition. Scientific Reports 9 (1) : 8295. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Aberrant activation of epithelial to mesenchymal transition (EMT) associated factors were highly correlated with increased mortality in cancer patients. SNAIL family of transcriptional repressors comprised of three members, each of which were essentially associated with gastrulation and neural crest formation. Among which, SNAI1 and SNAI2 were efficiently induced during EMT and their expressions were correlated with poor clinical outcome in patients with breast, colon and ovarian carcinoma. In an ovarian cancer cell lines panel, we identified that SNAI1 and SNAI2 expressions were mutually exclusive, where SNAI1 predominantly represses SNAI2 expression. Detailed analysis of SNAI2 promoter region revealed that SNAI1 binds to two E-box sequences that mediated transcriptional repression. Through epigenetic inhibitor treatments, we identified that inhibition of histone deacetylase (HDAC) activity in SNAI1 overexpressing cells partially rescued SNAI2 expression. Importantly, we demonstrated a significant deacetylation of histone H3 and significant enrichments of HDAC1 and HDAC2 corepressors in both E-box regions of SNAI2 promoter. Our results suggested that SNAI1 repression on SNAI2 expression was predominantly mediated through the recruitment of the histone deacetylation machinery. Utilization of HDAC inhibitors would require additional profiling of SNAI1 activity and combined targeting of SNAI1 and HDACs might render efficient cancer treatment. © 2019, The Author(s).
Source Title: Scientific Reports
ISSN: 2045-2322
DOI: 10.1038/s41598-019-44826-8
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41598-019-44826-8.pdf1.72 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons